Princeton, NJ, United States of America

Miguel A Ondetti


 

Average Co-Inventor Count = 1.8

ph-index = 24

Forward Citations = 2,090(Granted Patents)

Forward Citations (Not Self Cited) = 1,894(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • North Brunswick, NJ (US) (1976)
  • Princeton, NJ (US) (1976 - 1993)

Company Filing History:


Years Active: 1976-1993

Loading Chart...
Loading Chart...
Areas of Expertise:
Vasorelaxant Action
Restenosis Prevention
Atherosclerosis Regression
Enkephalinase Inhibitors
Antibacterial Compounds
Angiotensin Related Hypertension
Mercaptoacyl Derivatives
Mixed Disulfides
Hydroxamic Acid Derivatives
Amino Acid Derivatives
Thiazolidinecarboxylic Acids
Hypertension Relief
100 patents (USPTO):Explore Patents

Title: Miguel A. Ondetti: Pioneering Innovator in Cardiovascular Health

Introduction:

Miguel A. Ondetti, a distinguished inventor based in Princeton, NJ (US), is renowned for his exceptional contributions to the field of cardiovascular health. With an impressive portfolio of 100 patents, Ondetti's relentless pursuit of innovation continues to inspire generations of inventors and researchers worldwide.

Latest Patents:

Among his latest patents is a groundbreaking method for rehabilitating the vasorelaxant action of the coronary arteries. This innovative approach involves the use of angiotensin-converting enzyme inhibitors to prevent arteriospasm in individuals with impaired endothelium due to atherosclerosis and/or hypercholesterolemia. Another notable patent focuses on preventing restenosis after angioplasty by administering ACE inhibitors prior to, during, and after the procedure.

Career Highlights:

Miguel A. Ondetti has made significant strides in his career at E.R. Squibb & Sons, Inc., a renowned pharmaceutical company known for its groundbreaking research in cardiovascular medicine. His pioneering work has not only advanced the field of cardiovascular health but has also contributed to the development of innovative treatment strategies for a range of cardiovascular conditions.

Collaborations:

Throughout his illustrious career, Ondetti has collaborated with esteemed colleagues, including David W. Cushman and Michael E. Condon. Together, they have spearheaded groundbreaking research projects that have reshaped the landscape of cardiovascular medicine and paved the way for cutting-edge therapeutic interventions.

Conclusion:

In conclusion, Miguel A. Ondetti's remarkable achievements and unwavering commitment to innovation have left an indelible mark on the field of cardiovascular health. His groundbreaking inventions have not only revolutionized treatment approaches but have also set a new standard for excellence in medical research. Ondetti's legacy continues to inspire inventors and researchers to push the boundaries of possibility in the pursuit of groundbreaking discoveries in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…